11.20.2018
Diagnostics
$1,604,000.00
42 months
Advancing an ingestible micro-bio-electronic device (IMBED) to diagnose and monitor Crohn's disease
This study will help to develop novel technologies that will allow for the detection of biomarkers within the intestinal tract of CD and potentially result in improved diagnosis and targeted, precision medicine approaches for Crohn's disease patients.